Spinal cord injury

Routinely measured haematological markers can help to predict AIS scores following spinal cord injury
A follow up to our perliminary paper with a larger cohort
Routinely measured haematological markers can help to predict AIS scores following spinal cord injury
Biomarkers and prognostic modelling in SCI using proteomics, bioinformatics and in vitro models
Funded by the EPSRC (UKRI)
Biomarkers and prognostic modelling in SCI using proteomics, bioinformatics and in vitro models
A Preliminary Cohort Study Assessing Routine Blood Analyte Levels and Neurological Outcome Following Spinal Cord Injury
A preliminary investigation into the value of routine bloods for prognosis of spinal cord injury
A Preliminary Cohort Study Assessing Routine Blood Analyte Levels and Neurological Outcome Following Spinal Cord Injury
Evaluating patient perspectives on participating in scientific research and clinical trials for the treatment of spinal cord injury
Evaluating patient perspectives on participating in scientific research and clinical trials for the treatment of spinal cord injury
Spinal motor neurite outgrowth over glial scar inhibitors is enhanced by coculture with bone marrow stromal cells
Concise Review: Bone Marrow for the Treatment of Spinal Cord Injury: Mechanisms and Clinical Applications
The cell culture expansion of bone marrow stromal cells from humans with spinal cord injury: implications for future cell transplantation therapy
Bone marrow stromal cells stimulate neurite outgrowth over neural proteoglycans (CSPG), myelin associated glycoprotein and Nogo-A